Vancouver, British Columbia, Canada Accel-Rx Health Sciences Accelerator appeared to be the VC, which was created in 2014. The leading representative office of defined VC is situated in the Vancouver. The company was established in North America in Canada.
The high activity for fund was in 2016. The fund is generally included in less than 2 deals every year. Deals in the range of 1 - 5 millions dollars are the general things for fund. Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Flosonics, Inversago Pharma. The fund has no specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Clinical Trials. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Accel-Rx Health Sciences Accelerator, startups are often financed by StartUp Health. The meaningful sponsors for the fund in investment in the same round are BDC Venture Capital, Lumira Ventures, Genesys Capital. In the next rounds fund is usually obtained by Lumira Ventures, Remiges Ventures, Fonds de solidaritu00e9 FTQ.
Related Funds
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Inversago Pharma | $7M | 25 Jul 2018 | Montreal, Quebec, Canada | ||
Flosonics | $5M | 29 Jan 2018 | Greater Sudbury, Ontario, Canada | ||
Sepset Biosciences | 01 Jan 2018 | Vancouver, British Columbia | |||
KalGene Pharmaceuticals | 27 Nov 2017 | Canada, Ontario | |||
SpecificiT Pharma | 11 Sep 2017 | Montreal, Quebec, Canada | |||
Zucara Therapeutics | $525K | 03 Nov 2016 | Vancouver, British Columbia | ||
Soundbite Medical Solutions | $5M | 31 Oct 2016 | Montreal, Quebec, Canada | ||
KisoJi Biotechnology | 12 Oct 2016 | Laval, Quebec, Canada | |||
ImStar Therapeutics | $1M | 08 Jun 2016 | Vancouver, British Columbia, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Inversago Pharma | $7M | 25 Jul 2018 | Montreal, Quebec, Canada | ||
Flosonics | $5M | 29 Jan 2018 | Greater Sudbury, Ontario, Canada | ||
Sepset Biosciences | 01 Jan 2018 | Vancouver, British Columbia | |||
KalGene Pharmaceuticals | 27 Nov 2017 | Canada, Ontario | |||
SpecificiT Pharma | 11 Sep 2017 | Montreal, Quebec, Canada | |||
Zucara Therapeutics | $525K | 03 Nov 2016 | Vancouver, British Columbia | ||
Soundbite Medical Solutions | $5M | 31 Oct 2016 | Montreal, Quebec, Canada | ||
KisoJi Biotechnology | 12 Oct 2016 | Laval, Quebec, Canada | |||
ImStar Therapeutics | $1M | 08 Jun 2016 | Vancouver, British Columbia, Canada |
